Can You Prescribe Two 37.5 mg Tablets of Venlafaxine?
Yes, you can prescribe two 37.5 mg tablets of venlafaxine (total 75 mg daily), and this is actually the recommended starting dose for adults with depression. This dosing approach is explicitly supported by FDA labeling and clinical guidelines.
Starting Dose Recommendations
The FDA-approved prescribing information for venlafaxine immediate-release specifies that 75 mg/day is the recommended starting dose, administered in two or three divided doses, taken with food 1. This means prescribing two 37.5 mg tablets is a standard and appropriate initial dosing strategy.
Multiple clinical practice guidelines consistently recommend this approach:
- For neuropathic pain: Starting dose is 37.5 mg once or twice daily (total 50-75 mg), with increases by 75 mg each week up to 225 mg/day 2
- For depression: The 37.5 mg twice daily regimen is well-established, with dose increases to 75 mg twice daily (150 mg total) if clinically indicated after 2 weeks 3
- For painful diabetic neuropathy: Starting dose is 150-225 mg/day as the therapeutic target 4
Dosing Flexibility: BID vs TID
Research demonstrates that dividing the daily dose into either 2 or 3 administrations provides equivalent drug exposure and efficacy 5. A pharmacokinetic study showed that 75 mg twice daily versus 50 mg three times daily resulted in bioequivalence ratios of 96-100% for both venlafaxine and its active metabolite O-desmethylvenlafaxine, with 90% confidence intervals within 90-110%. This gives you flexibility in prescribing—two tablets daily is as effective as three smaller doses.
Titration Strategy
After starting at 75 mg/day (two 37.5 mg tablets):
- Assess response after 2 weeks
- If inadequate response: Increase to 150 mg/day (can be given as 75 mg twice daily)
- Further increases: Up to 75 mg/day increments at intervals of no less than 4 days 1
- Maximum dose: 225 mg/day for outpatients; up to 375 mg/day for severely depressed inpatients
Clinical trials show that doses from 75-225 mg/day are superior to placebo, with suggestive dose-response relationships in this range 1.
Important Prescribing Considerations
Monitor blood pressure: Venlafaxine can cause sustained hypertension and blood pressure increases, particularly at higher doses 2. Check BP before starting and regularly during treatment.
Cardiac precautions: Cardiac conduction abnormalities have been reported in a small number of patients. Prescribe with caution in patients with cardiac disease 2.
Renal/hepatic impairment:
- Reduce total daily dose by 25% in mild-to-moderate renal impairment
- Reduce by 50% in hemodialysis patients or hepatic impairment 1
Discontinuation syndrome: Venlafaxine must be tapered when discontinuing—never stop abruptly. A withdrawal syndrome with dizziness, nausea, paresthesias, and anxiety has been well-documented 2.
Take with food: This improves tolerability and reduces nausea, which is the most common adverse effect (occurring in 28-44% of patients) 6.
Common Pitfalls to Avoid
- Don't start at higher doses: While 150-225 mg/day is the therapeutic target for many conditions, starting at 75 mg/day minimizes adverse effects and allows tolerance to develop
- Don't forget to taper: The short half-life of immediate-release venlafaxine makes discontinuation symptoms more likely if stopped abruptly
- Don't ignore cardiovascular monitoring: Regular BP checks are essential, especially when increasing doses
- Don't use in pregnancy (third trimester) without careful risk-benefit assessment: Neonates exposed late in pregnancy may require prolonged hospitalization 1